By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
The Washington DigestThe Washington Digest
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
Reading: Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
Share
Notification Show More
Latest News
Spend with Ukraine: Supporting a War-torn Economy
February 6, 2023
A Look Back at January 24th in Tennessee’s History
January 24, 2023
Explore Washington’s Top 10 Entertainment Destinations
January 19, 2023
Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry
January 4, 2023
The Role of Big Data in Modern Public Relations: How PR Professionals are Leveraging Data to Improve Outcomes
January 2, 2023
Aa
Aa
The Washington DigestThe Washington Digest
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
  • Politics
  • Business
  • World
  • Lifestyle
  • Sports
  • Technology
  • Education
  • Contact
  • Submit a News Release
Have an existing account? Sign In
Follow US
  • Home
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
The Washington Digest > Health > Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
Health

Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’

Beverly Clements
Beverly Clements August 5, 2022
Updated 2022/08/05 at 2:43 AM
Share
SHARE

“Regardless of the outcome in the coming weeks, this fight isn’t over,” Ubl said in an interview. “Few associations have all the tools of modern political advocacy at their disposal in the way that PhRMA does.”

Thursday’s letter largely reiterates arguments the industry has made throughout the process, with the executives from companies including Pfizer and Merck saying that passing the legislation would lead to fewer treatments and cures — particularly for tough illnesses like cancer and Alzheimer’s disease that can be difficult and costly to develop.

Ubl said that one of PhRMA’s member companies has 15 drugs in the pipeline that would be nixed if the bill becomes law.

“This is a very consequential vote. Those members who vote for this bill will not get a free pass. We’ll do whatever we can to hold them accountable,” he said.

It’s unclear when Senate Majority Leader Chuck Schumer will bring the $740 billion reconciliation package to the floor, and senators anticipate having to stay over the weekend as they move to work out any kinks and pass it as quickly as possible.

The stakes are high for the drug industry: allowing Medicare to negotiate the cost of high-price drugs is expected to save the federal government more than $100 billion. The move would “put the U.S. system on a course toward broad government control, setting the stage for our country to fall behind,” reads the letter sent to Congress on Thursday.

PhRMA has spent millions of dollars lobbying on Democrats’ drug pricing reform measures over the past two years, and millions more on TV and digital advertisements trying to sway public opinion. In the first six months of 2022, the group’s overall lobbying operation spent more than $14.4 million, according to disclosure filings.

Ubl declined to talk more about what kinds of legal arguments would be on the table — “for fear that tipping our hand would foreclose future options” — or what changes could come from future regulations or legislation.

“From my experience, when a bill like this is pursued on a hyperpartisan basis, with slim margins and deficiencies in due process, it rarely sticks,” he said, pointing to all the changes that have been made to the Affordable Care Act since its passage. “I would expect there’ll be opportunities to further mitigate the harms of this legislation going forward.”

READ NEWS SOURCE

The post Pharma group leader says Dems who vote for reconciliation bill 'won't get a free pass' appeared first on thewashingtondigest.com.

You Might Also Like

Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry

Nurse practitioner says CVS fired her over abortion stance

Sonia Sotomayor denies NYPD detective’s plea to block vaccine mandate

FDA expected to authorize Moderna, Pfizer-BioNTech Omicron boosters

Hackers have laid siege to U.S. health care and a tiny HHS office is buckling under the pressure

Beverly Clements August 5, 2022
Share this Article
Facebook TwitterEmail Print
Previous Article HHS’ Rachel Levine: Long COVID will affect U.S. for ‘years to come’
Next Article Russia-Ukraine war: A weekly recap and look ahead (Aug. 8)
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Spend with Ukraine: Supporting a War-torn Economy
Business
A Look Back at January 24th in Tennessee’s History
Lifestyle
Explore Washington’s Top 10 Entertainment Destinations
Entertainment
Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry
Health

You Might Also Like

Health

Exploring the Controversy Surrounding Pharmaceutical Marketing Agencies in Washington’s Healthcare Industry

January 4, 2023
Health

Nurse practitioner says CVS fired her over abortion stance

September 1, 2022
Health

Sonia Sotomayor denies NYPD detective’s plea to block vaccine mandate

September 1, 2022
Health

FDA expected to authorize Moderna, Pfizer-BioNTech Omicron boosters

September 1, 2022
//

In politics, if you want anything said, ask a man; if you want anything done, ask a woman.

Contact Us

If you have any questions please contact us by email:

ask@thewashingtondigest.com

© 2022 thewashingtondigest.com. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?